Magazine Article | June 1, 2018

Is The U.S. Biosimilar Industry Falling Behind?

Source: Life Science Leader


Eighty-seven percent of global biosimilar sales come from the E.U., compared to just 2 percent from the U.S. We asked outsourced biomanufacturing decision-makers from North America and Europe to share their companies’ stances on selling and manufacturing biosimilars.